Lipid Management Connect
Profile Image
Add Media
  • Saved

7mo
Advances in the Diagnosis and Management of High-Risk Cardiovascular Conditions: Biomarkers, Intracoronary Imaging, Artificial Intelligence, and Novel Anticoagulants - PubMed

Advances in the Diagnosis and Management of High-Risk Cardiovascular Conditions: Biomarkers, Intracoronary Imaging, Artificial Intelligence, and Novel Anticoagulants - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41590879/

Understanding thrombosis in acute coronary syndromes (ACSs) has evolved through advances in biomarkers, intracoronary imaging, and emerging analytical tools, improving diagnostic accuracy and risk stratification in high-risk patients. This narrative...

This review highlights advances in ACS care using biomarkers, intracoronary imaging, AI, and novel anticoagulants, enabling improved diagnosis, risk stratification, and personalized management, while emphasizing the need for further validation.

Profile Image
  • Uploads
  • Saved

7mo
Progress in risk assessment and management: Forecasting updates across international cholesterol guidelines - PubMed

Progress in risk assessment and management: Forecasting updates across international cholesterol guidelines - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41624043/

In anticipation of updates to cholesterol guidelines globally, evidence since the most recent iteration of recommendations across US and Europe for risk assessment and lipid management are reviewed. ASCVD risk...

Review forecasts global cholesterol guideline updates emphasizing PREVENT risk equations, coronary calcium, lower LDL-C targets, and combination lipid-lowering therapy including statins, ezetimibe, bempedoic acid, and PCSK9 inhibitors for high-risk patients.

Profile Image
  • Uploads
  • Saved

7mo

Did you know? Hormonal imbalances can subtly influence lipid metabolism, insulin sensitivity, body weight, and renal function. Disruptions in calcium, vitamin D, and magnesium signaling may amplify cardiometabolic risk, underscoring the need for integrated endocrine monitoring across obesity, diabetes, and lipid disorders to support long-term metabolic health.

Could a more holistic approach to hormonal monitoring improve cardiometabolic outcomes across diverse metabolic conditions?

NCCN Guidelines

Could a more holistic approach to hormonal monitoring improve cardiometabolic outcomes across diverse metabolic conditions?

Profile Image
  • Uploads
  • Saved

7mo
Background Image DesktopBackground Image Mobile

Emerging evidence links hormonal imbalance to metabolic dysfunction, oxidative stress, and elevated cardiovascular risk. Conditions marked by insulin resistance, dyslipidemia, and obesity share disrupted endocrine signaling that accelerates cardiometabolic complications across populations.

Explore endocrine–metabolic connections

Profile Image
  • Uploads
  • Saved

7mo
Profile Image
  • Uploads
  • Saved

7mo
Efficacy and Safety of Steamed Ginger Extract for Body Weight and Body Fat Reduction in Overweight Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial - PubMed

Efficacy and Safety of Steamed Ginger Extract for Body Weight and Body Fat Reduction in Overweight Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41599979/

Twelve weeks of GGE03 supplementation were associated with statistically significant improvements in body composition and lipid parameters without safety concerns. These findings support the potential of GD-standardized GGE03 as a...

This randomized trial shows GD-standardized steamed ginger extract significantly reduced body fat, weight, and lipid levels over 12 weeks in overweight adults, with good tolerability and no safety concerns.

Profile Image
  • Uploads
  • Saved

8mo

Opportunistic Genomic Screening for Familial Hypercholesterolemia to Improve Low-Density Lipoprotein Cholesterol: A Randomized Clinical Trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41511773/

ClinicalTrials.gov Identifier: NCT04178122.

Randomized trial found opportunistic genomic screening for familial hypercholesterolemia with telegenetic counseling showed no statistically significant LDL-C reduction, though trends suggested modest benefit and increased treatment intensification.

Profile Image
  • Uploads
  • Saved

8mo
Effect of Nordic Walking on Anthropometrics, Glycemia, and Lipid Profile in Adults With Prediabetes or Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed

Effect of Nordic Walking on Anthropometrics, Glycemia, and Lipid Profile in Adults With Prediabetes or Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41523744/

Nordic walking exerted beneficial effects on body weight, HbA1c, and HDL in adults with prediabetes or diabetes. Our findings support that Nordic walking can be a practical intervention in managing...

This meta-analysis found Nordic walking modestly reduced body weight and HbA1c, increased HDL and VO2peak, but showed limited effects on blood pressure, fasting glucose, or most lipid parameters in adults with diabetes or prediabetes.

Profile Image
  • Uploads
  • Saved

8mo
Electroacupuncture Reduces Waistline in Patients with Abdominal Obesity: A Randomized Controlled Trial with Mechanistic Analysis of Lipidomic and Intestinal Microbiota - PubMed

Electroacupuncture Reduces Waistline in Patients with Abdominal Obesity: A Randomized Controlled Trial with Mechanistic Analysis of Lipidomic and Intestinal Microbiota - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41050180/

Our findings suggest that electroacupuncture is effective and safe in reducing waistline in patients with abdominal obesity. These results provide preliminary evidence that its benefits may be related to changes...

Randomized trial shows electroacupuncture plus lifestyle intervention significantly reduced waist circumference in abdominal obesity, with sustained benefits, associated with favorable lipidomic shifts and microbiota changes, including increased Akkermansia muciniphila abundance.

Profile Image
  • Uploads
  • Saved

8mo
Electroacupuncture Reduces Waistline in Patients with Abdominal Obesity: A Randomized Controlled Trial with Mechanistic Analysis of Lipidomic and Intestinal Microbiota - PubMed

Electroacupuncture Reduces Waistline in Patients with Abdominal Obesity: A Randomized Controlled Trial with Mechanistic Analysis of Lipidomic and Intestinal Microbiota - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41050180/

Our findings suggest that electroacupuncture is effective and safe in reducing waistline in patients with abdominal obesity. These results provide preliminary evidence that its benefits may be related to changes...

Profile Image
  • Uploads
  • Saved

8mo
Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials - PubMed

Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41470853/

Background: Type 2 diabetes mellitus (T2DM) is a growing global health challenge requiring effective dietary management strategies. While the Mediterranean diet shows promise for cardiovascular and metabolic health, the last...

Meta-analysis of RCTs shows Mediterranean diet modestly improves glycemic control, BMI, lipids, and blood pressure in type 2 diabetes, supporting its culturally adaptable role in cardiometabolic risk management.

Profile Image
  • Uploads
  • Saved

9mo
Background Image DesktopBackground Image Mobile

Managing diabetes in pregnancy requires a dual approach: lifestyle changes like diet and exercise, plus targeted drug therapy with insulin or antihyperglycemics. Early action, patient education, and tools like CGM and telemedicine enhance glycemic control and outcomes.

Explore strategies for safer diabetic pregnancies

Profile Image
  • Uploads
  • 9mo
    Individualized meal plans focusing on: • Controlled carbohydrate distribution • Low–glycemic index foods • Adequate calories for fetal growth (avoid overly restrictive diets) Moderate exercise (e.g., walking 10–15 minutes after meals) • Improves postprandial glucose and insulin sensitivity
  • Saved

9mo
Familial hypercholesterolemia: closing the gap between diagnosis and effective LDL-C control

Familial hypercholesterolemia (FH) is often called the “silent accelerant” of cardiovascular risk. From early in life, patients carry LDL-C levels that standard therapy rarely brings to target, resulting in decades of cumulative cholesterol exposure and a significantly elevated risk for premature ASCVD events.

Despite this, FH remains under-recognized—fewer than 1 in 10 patients are ever diagnosed. Missed opportunities for cascade screening and delayed follow-up testing mean many families stay at risk until a major event occurs. Even when FH is identified, achieving LDL-C targets aligned with clinical guidelines remains a challenge.

Clinical data continue to support timely intensification of therapy when conventional approaches fall short. Inhibition of the PCSK9 pathway has been associated with nearly 50% reductions in LDL-C, with added improvements in ApoB and lipoprotein(a). A 2025 meta-analysis showed these effects in both adults and children with FH, reinforcing the importance of early and aggressive intervention in high-risk cases.

Yet real-world care is rarely straightforward. Some patients show a weaker-than-expected response, often linked to missed doses, elevated lipoprotein(a), or genetic variability. Others face barriers tied to access, coverage, or fragmented care, but progress depends on detection, intensification, and follow-up.

How are you identifying FH patients earlier in your practice? When do you escalate therapy—and what has helped sustain LDL-C control long term?

Profile Image
  • Uploads
  • 9mo
    Patients with very high LDL cholesterol, especially when this does not improve significantly with lifestyle and behavioral/dietary modification and those with physical features suggesting FH as well as early family Show More
  • 9mo
    Screen all pts in my clinic with a lipid panel, pts with LDLC >190 are likely to have FH, some pts proceed to genetic testing. Treat aggressively with PCSK 9, Show More

Show More Comments

  • Saved

9mo
Expert Review of the Strategies to Optimize Long-Term Outcomes After Coronary Artery Bypass Grafting - PubMed

Expert Review of the Strategies to Optimize Long-Term Outcomes After Coronary Artery Bypass Grafting - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41356289/

Coronary artery bypass grafting (CABG) remains a cornerstone in the treatment of advanced ischemic heart disease, offering durable and effective revascularization. Despite surgical success, long-term patient outcomes are often shaped...

CABG success depends on strong secondary prevention. Optimizing medications, arrhythmia management, lifestyle change, psychological health, ventricular function, and multidisciplinary care improves long-term outcomes, with primary care central to sustained recovery.

Profile Image
  • Uploads
  • Saved

9mo
Update on Tree Nut and Seed Allergies: Prevalence, Clinical Characteristics, Diagnosis, and Management - PubMed

Update on Tree Nut and Seed Allergies: Prevalence, Clinical Characteristics, Diagnosis, and Management - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41330701/

Tree nut (TN) and seed allergies have become increasingly recognized as important global health concerns, paralleling rising consumption driven by dietary trends. These allergies are often severe, typically develop in...

Profile Image
  • Uploads
  • Saved

9mo
Clinical features and genetic analysis of a Brazilian patient with sitosterolemia: a case report - PubMed

Clinical features and genetic analysis of a Brazilian patient with sitosterolemia: a case report - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/40532043/

Sitosterolemia is a rare genetic lipid disorder caused by mutations in the ABCG5/ABCG8, genes. It is characterized by plasmatic plant sterols accumulation, formation of tendon and tuberous xanthomas and early...

Brazilian man with early xanthomas, thrombocytopenia, and premature MI was diagnosed with sitosterolemia due to homozygous ABCG8 mutation; dietary plant-sterol restriction plus ezetimibe led to marked clinical improvement.

Profile Image
  • Uploads
  • Saved

10mo
AHA Scientific Sessions 2025: Transformative advances in cardiovascular care

Dr. Joanna Chikwui, Chief of Cardiac Surgery at Cedars-Sinai and Chair of AHA Scientific Sessions, spotlighted significant breakthroughs across cardiology. Updates included novel therapies for hyperlipidemia, gene-editing tools for inherited cardiovascular risk, innovations in atrial fibrillation management, and compelling lifestyle findings—including a surprising inverse relationship between moderate coffee intake and AF incidence.

Dr. Heidi May, Epidemiologist at Intermountain Health, presented results from the Target-D randomized trial, which found that personalized vitamin D dosing after myocardial infarction significantly reduced the risk of recurrent heart attack. These findings underscore the importance of individualized supplementation strategies and signal a broader shift toward precision prevention and risk stratification in cardiovascular care.

Share your thoughts

Profile Image
  • Uploads
  • Saved

10mo
Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review - PubMed

Use of intravenous lipid emulsions in drug-induced toxicities: a 2025 narrative review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/41247632/

Intravenous lipid emulsions (ILE) were first proposed in 1998 as a treatment for bupivacaine-induced cardiac arrest. Since then, their use has expanded to include poisonings by various lipophilic drugs such...

ILEs treat lipophilic drug toxicities through lipid sink, shuttle, and cardiotonic mechanisms; benefits shown in select poisonings, but mortality impact, optimal dosing, and indications remain uncertain, requiring higher-quality evidence.

 

Profile Image
  • Uploads
  • Saved

10mo
infographic
Profile Image
  • Uploads
  • Saved

10mo

Fun Fact! Statin-associated liver injury (SILI) is rare, with true liver damage seen in just 1 in 1,000 to 1 in 10,000 patients. Though 2.8–3.1% show elevated liver enzymes, most cases are mild and resolve after stopping treatment. Interestingly, statins may offer protection against chronic liver diseases like cirrhosis.

Could statins play a dual role in both managing cholesterol and protecting liver health?

NCCN Guidelines

Could statins play a dual role in both managing cholesterol and protecting liver health?

Profile Image
  • Uploads